Global Perspectives and Clinical Resources on BTK Inhibitor Therapy for Patients With CLL

In this program focused on global perspectives, get up to date on key topics in the use of BTK inhibitors for treating CLL with an expert-authored interactive text module and short commentary, downloadable slides, and Interactive Decision Support Tools for CLL and BTK inhibitor AE management.

Share

Program Content

Activities

BTKis for CLL: Module
BTK Inhibitor Therapy for Patients With CLL: A Global Perspective
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: March 13, 2023

Expires: March 12, 2024

Activities

Managing BTKi AEs Global
Interactive Tool for Managing BTK Inhibitor−Associated AEs in Hematologic Malignancies: A Global Perspective
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: August 15, 2023

Global CLL Treatment Tool
Expert Guidance for the Treatment of CLL: An International Perspective
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: May 01, 2023

Activities

BTKis for CLL
BTK Inhibitor Therapy for CLL: An International Perspective
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 28, 2023

Expires: March 27, 2024

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca